Selected article for: "ace enzyme and acute respiratory syndrome"
Author: Turner, Anthony J.
Title: ACE2 Cell Biology, Regulation, and Physiological Functions
  • Cord-id: 5yzsoey3
  • Document date: 2015_4_24
    • ID: 5yzsoey3
    Snippet: Angiotensin-converting enzyme 2 (ACE2), discovered as a homologue of ACE, acts as its physiological counterbalance providing homeostatic regulation of circulating angiotensin II (Ang II) levels. ACE2 is a zinc metalloenzyme and carboxypeptidase located as an ectoenzyme on the surface of endothelial and other cells. While its primary substrate appears to be Ang II, it can hydrolyze a number of other physiological substrates. Additionally, ACE2 functions in other noncatalytic cellular roles includ
    Document: Angiotensin-converting enzyme 2 (ACE2), discovered as a homologue of ACE, acts as its physiological counterbalance providing homeostatic regulation of circulating angiotensin II (Ang II) levels. ACE2 is a zinc metalloenzyme and carboxypeptidase located as an ectoenzyme on the surface of endothelial and other cells. While its primary substrate appears to be Ang II, it can hydrolyze a number of other physiological substrates. Additionally, ACE2 functions in other noncatalytic cellular roles including the regulation of intestinal neutral amino acid transport. It also serendipitously acts as the receptor for the severe acute respiratory syndrome virus. Upregulation of ACE2 expression and function is increasingly recognized as a potential therapeutic strategy in hypertension and cardiovascular disease, diabetes, lung injury, and fibrotic disorders. ACE2 is regulated at multiple levels including transcriptional, posttranscriptional (miRNA and epigenetic), and posttranslational through its shedding from the cell surface.

    Search related documents:
    Co phrase search for related documents
    • ace homologue and acute lung injury: 1, 2, 3, 4
    • ace homologue and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
    • ace homologue and liver fibrosis: 1, 2, 3
    • ace homologue and lung injury: 1, 2, 3, 4, 5, 6, 7
    • ace inhibition and acute lung injury: 1, 2, 3
    • ace inhibition and acute respiratory syndrome: 1, 2, 3, 4, 5, 6
    • ace inhibition and lung injury: 1, 2, 3, 4
    • ace inhibitor and acute lung injury: 1, 2, 3, 4
    • ace inhibitor and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • ace inhibitor and lung injury: 1, 2, 3, 4
    • ace overexpression and acute respiratory syndrome: 1, 2, 3, 4
    • ace unlike and acute respiratory syndrome: 1, 2
    • ace unlike and lung injury: 1
    • acute lung injury and ad animal model: 1
    • acute lung injury and lung injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory syndrome and ad animal model: 1
    • acute respiratory syndrome and liver fibrosis: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • acute respiratory syndrome and local level: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory syndrome and lung injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25